A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Expanded access is no longer available for this treatment.
Study NCT00511771
Information provided by Novartis
First Received: August 3, 2007
Last Updated: April 10, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
